Академический Документы
Профессиональный Документы
Культура Документы
Correspondence
jenki002@umn.edu
In Brief
Immune responses to some antigens are
stronger than others. The findings of
Nelson and colleagues indicate that a
T cell response can be weak because the
eliciting foreign peptide resembles a self
peptide to which the host is tolerant.
Highlights
d MHCII-bound nonamer peptides need to only share five
residues to bind the same TCR
Article
200K 200K
10 4 10 4
SSC-A
SSC-A
150K 150K
CD8
10 3 10 3
100K 100K
10 2 0
50K 50K 0
0 0
0 50K 100K 150K 200K 250K 0 50K 100K 150K 200K 250K 0 10 2 10 3 10 4 10 5 0 10 3 10 4 10 5
FSC-A SSC-W CD90.2 CD4
B Unimmunized Day 14 after immunization
10 5 10 5 10 5 10 5
ESAT6:I-Ab
ESAT6:I-Ab
4
10 10 4 10 4 10 4
CD44
CD44
10 3 10 3 10 3 10 3
10 2
0 0 0 0
0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 3 10 4 10 5 0 10 3 10 4 10 5
ESAT6:I-Ab
10 5 10 5 10 5 10 5
Calnexin:I-Ab
Calnexin:I-Ab
10 4 10 4 10 4 10 4
CD44
CD44
10 3 10 3 10 3 10 3
10 2
0 0 0 0
0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 3 10 4 10 5 0 10 3 10 4 10 5
Calnexin:I-Ab
10 5 10 5 10 5 10 5
CD4Ag28m:I-Ab
CD4Ab28m:I-Ab
10 4 10 4 10 4 10 4
CD44
CD44
10 3 10 3 10 3 10 3
1.7
10 2 0
0 0
0
0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 3 10 4 10 5 0 10 3 10 4 10 5
CD4Ag28m:I-Ab
C 106
105
p:I-Ab+ cells
104
103
102
101
1
8m
6
4A W
C 3K
6
M FliC
15 3
eG 1
xin
3C
2C
1W
1G sf
TB
O pIF
Cd 1
-1
O P
D O
Pm a2
P6
AT
M 0-
p
F
Aa
LL
40
pG
D 2
g2
er
ne
VA
VA
C
ST 154
G
ES
al
ST
D
E
Log10 (effector cell number)
6
Log10 (effector cell number)
6
IFN-γ ELISPOT
4 4
2 2
p < 0.0001 p < 0.0001
R2 = 0.64 R2 = 0.58
0 0
0 1 2 3 0 2 4 6
Log10 (naive cell number) Tetramer
Log10 (effector cell number)
Figure 1. Relationship between p:I-Ab-Specific CD4+ T Cell Population Sizes in Unimmunized and Immunized Mice
(A) Gates used to identify lymphocyte-sized, non-doublet, CD90.2+ B220 CD11b CD11c , CD4+ T cells.
(B) Contour plots of double tetramer staining (far left) or CD44 expression (left) for CD4+ T cells from spleen and lymph nodes identified as in (A) from individual
unimmunized B6 mice following enrichment with the indicated p:I-Ab tetramers labeled with streptavidin-PE (x axis) or streptavidin-APC (y axis). The plots on the
right represent similar staining for populations in spleen and draining lymph nodes 14 days after subcutaneous injection with 10 mg of the relevant peptide
emulsified in CFA.
(C) Total number of tetramer-binding CD4+ T cells per mouse for I-Ab-bound peptides in individual unimmunized (open circles) or immunized (filled circles) mice
identified as in (B). Horizontal bars indicate mean values. The depicted results were pooled from 11 independent experiments.
(D) Linear correlation between the average log10 naive and effector cell number for each of the populations identified in (C).
(E) Linear correlation between the average log10 effector cell number obtained by tetramer staining (x axis) or ELISPOT (y axis), 14 days after subcutaneous
injection of 19 peptides from (C) emulsified in CFA. The depicted results were from one experiment with the mean of three values from individual mice for each
peptide for the tetramer enrichment assay and the mean of two values from individual mice for the ELISPOT assay.
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
LLO:I-Ab No peptide
CD44
L. lactis YKLPYSFKR
L. byssophila (GP66)
No peptide YKGTYPFKN YKGVYQFKS L. amylovorus YKWTYPFKA
105 105 105 Z. galactanivorans YKDSYPFKE
104 104 104 L. byssophila YKGTYPFKN
103 103 103 (GP66) YKGVYQFKS
102 102 102
0 0 0
No peptide
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
2W:I-Ab
foreign peptides shown in Table 1 (Figure S1). The stringency of population size. Earlier work indicated that self p:MHCII-specific
the search was reduced to include any combination of 4 out of 5 T cells that survived clonal deletion bound tetramer poorly due to
identical amino acid residues at P2, 3, 5, 7, and 8 to capture any expression of low-affinity TCRs (Moon et al., 2011; Zehn and
self peptide that could have an effect. Mouse-peptide homologs Bevan, 2006). On the basis of this observation, we determined
were identified for all the foreign peptides, with a range of 3 to whether tetramer binding intensity could be used to identify
183 (Table S1). A significant inverse correlation was observed foreign p:MHCII-specific populations that experienced clonal
between naive CD4+ T cell population size and the number of deletion on a related self p:MHCII ligand. Indeed, as shown in
self-peptide homologs (Figure 4G), although the r2 value was Figure 5A, 2W109:I-Ab-specific naive T cells in Act-2W mice
only 0.27. These results support the conclusion that TCR bound 2W109:I-Ab tetramer less well than the comparable
cross-reactivity on self-peptide homologs plays some role in population in B6 mice. This difference was not observed for
determining the size of MHCII-bound foreign peptide-specific LLO:I-Ab-specific T cells in these strains, indicating that it re-
CD4+ T cell populations. sulted as a consequence of 2W:I-Ab complexes in Act-2W
mice. Thus, clonal deletion on a self p:MHCII ligand produced
Small Foreign p:MHCII-Specific T Cell Populations a smaller and lower-affinity population of T cells specific for a
Contain Cells with Low-Affinity TCRs related foreign p:MHCII ligand.
The relatively weak correlation in Figure 4G spurred a search for On the basis of this result, we determined whether the small
additional evidence that clonal deletion sculpts naive CD4+ T cell foreign p:MHCII-specific naive populations had this fingerprint
100 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.
A B 104
(P) 1 2 3 4 5 6 7 8 9 ***
2W EAWGALANWAV
p:I-Ab+ cells
2W109 EYWGPLPNWVV 103 n.s.
102
101
B6
2W109 LLO Act-2W
C 105 D n.s.
104 103
103 B6 *
***
102
2W:I-Ab
p:I-Ab+ cells
103 Act-2W
102
0
101
0 102 103 104 105
2W 2W109 2W and 2W109
2W109:I-A b
E
100
Fracton of response
80
to 2W109 (%)
60 B6
Act-2W
40
20
0
P-1A P1A P2A P3A P4A P5A P6A P7A P8A P9A P10A
F G
4 4
Log10 (naive cell number)
2 2
1 1
0 0
20 40 60 80 0 50 100 150 200
Reduction of reponse to parent peptide Number of homologous self peptides
by substitutions at P1, 4, 6, and 7 (%)
(C) Contour plots of 2W:I-Ab streptavidin-APC (y axis) versus 2W109:I-Ab streptavidin-PE (x axis) tetramer staining for CD4+ T cells from spleen and lymph nodes
from unimmunized B6 mice following enrichment with these tetramers.
(D) Number of CD4+ T cells in the spleen and lymph nodes of unimmunized B6 (filled circles) or Act-2W (open circles) mice that bound 2W:I-Ab tetramer only (upper
left quadrants in C); 2W109:I-Ab tetramer only (bottom right quadrants in C), or both 2W:I-Ab and 2W109:I-Ab tetramers (upper right quadrants in C) following
enrichment with these tetramers (***p < 0.0005, *p < 0.05, n.s. = not significant). The depicted results were from one experiment, which was representative of two
others.
(E) Eleven amino acid versions of 2W109 peptides with single alanine substitutions at the indicated positions were tested as stimulators of 2W109-primed CD4+
T cells from B6 (filled bars) or Act-2W (open bars) mice in an ELISPOT assay. The percentage of the response to the 2W109 peptide was determined by dividing
the number of spots stimulated by the alanine substituted peptide by the number of spots stimulated by the 2W109 peptide and multiplying by 100. The bars
represent the average values (±SD, n = 3 mice) from three independent experiments.
(F) Linear regression analysis of the log10 naive cell number versus the average percentage reduction of response to the parent peptide by alanine substitutions at
I-Ab anchor residues at P1, P4, P6, and P7. For each point, the y axis value represents the mean from Figure 1C for an individual peptide and the x axis value
represents the mean for that peptide from Figure 2B.
(G) Linear regression analysis of the log10 naive cell number versus the number of mouse peptides predicted to bind I-Ab and match each of the foreign peptides in
Table 1 at a minimum of four out of five TCR contact positions (P2, P3, P5, P7, P8). For each point, the y axis value represents the mean from Figure 1C for an
individual peptide. Spearman’s Rho test, a rank order test that makes no assumptions about linearity, also revealed a significant correlation between these
variables (p = 0.006), which was maintained even if the population with 183 self homologs was removed from the analysis (p = 0.02).
102 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.
A any of the anchor amino acids negated the reactivity of these
2500 *** T cells.
n.s. Several pieces of evidence indicated that naive p:I-Ab-spe-
2000
cific T cell populations of small size experienced extensive
Tetramer MFI
104 104 of predicted self peptides with similar TCR contacts is evidence
FliC:I-Ab
60 FliC:I-Ab likely influence naive cell population size (Chu et al., 2010; Turner
et al., 2005).
40 2W109:I-Ab Our findings might also be relevant for certain forms of auto-
20 immunity caused by tissue-restricted self peptides. We found
that one such peptide from MOG was recognized by a large
0 naive T cell population. The number of MOG:I-Ab-specific
0 102 103 104 105
PE tetramer MFI T cells might be even larger than described here because
some cells with low-affinity TCRs are probably not detected by
D p:MHCII tetramer staining (Sabatino et al., 2011). The large
4 size of the MOG:I-Ab-specific T cell population is consistent
Log10 (naive cell number)
Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc. 103
A B 103
105
MOG:I-Ab+ cells
105
MOG:I-Ab
104 104
b
MOG:I-A
101
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
b
MOG:I-A
D E
3
EAE combined clinical score
YRSPFSRVV
YRASFPRVR
2
YREAFARVR
YRDAFARVA 1
No peptide
0
100 101 102 103 104 5 10 15 20
b+
MOG:I-A cells Day
Figure 6. TCR Cross-Reactivity for Foreign Peptides Similar to MOG:I-Ab Can Elicit EAE
(A) Contour plots of double tetramer staining (left) or CD44 expression (right) for CD4+ T cells from spleen and lymph nodes from individual unimmunized B6 mice
following enrichment with MOG:I-Ab tetramers labeled with streptavidin-PE (x axis) or streptavidin-APC (y axis).
(B) Total number of MOG:I-Ab double tetramer-binding CD4+ T cells in individual unimmunized mice from two independent experiments. Horizontal bar indicates
the mean.
(C) Contour plots of clonal expansion and CD44 expression by MOG:I-Ab-specific cells 14 days after subcutaneous priming with 10 mg of the indicated peptides
emulsified in CFA.
(D) Average number of MOG:I-Ab+ CD4+ T cells after injection of 10 mg of the indicated peptides (±SEM, n = 3 mice/group). The depicted results were from one
experiment, which was representative of another.
(E) EAE course after subcutaneous injection of 100 mg of the peptides indicated in (D). The depicted results show mean disease score values (n = 5) for each
peptide from one experiment, which was representative of another.
be activated by a microbial mimic peptide. A similar situation and Strominger, 1995). These studies suggest that a better un-
might exist for humans as it has been shown that several micro- derstanding of TCR cross-reactivity and negative selection
bial peptides stimulated myelin basic protein peptide:HLA-D might make it possible to identify the infections that trigger
specific T cell clones (Birnbaum et al., 2014; Wucherpfennig autoimmunity.
104 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.
EXPERIMENTAL PROCEDURES Identification of Mouse Peptides with the Same TCR Contact Amino
Acids as Known Immunogenic Peptides
Mice The Mus musculus proteome was downloaded from the NCBI website
C57BL/6 (B6) mice were purchased from the Jackson Laboratory or the (ftp://ftp.ncbi.nlm.nih.gov/genomes/M_musculus/protein/protein.fa.gz). All
National Cancer Institute Mouse Repository. Act-2W (Moon et al., 2011) possible nine amino acid substrings were extracted from these peptide
mice were bred in our facilities. All mice were housed in specific pathogen- sequences and each substring was given an I-Ab-binding score based on a
free conditions at the University of Minnesota, and all experiments were con- published matrix (Zhu et al., 2003). The top 5% of predicted I-Ab-binding
ducted in accordance with institutional and federal guidelines. mouse peptides were then screened against the sequences of the foreign pep-
tides shown in Table 1 using custom C++ scripts to identify mouse peptides
p:MHCII Tetramer Production that shared 4 of 5 amino acids at positions 2, 3, 5, 7, and 8 with the foreign
pRMHa-3 vectors containing the alpha and beta chains of I-Ab under the con- peptides.
trol of the metallothionein promoter were constructed as previously described
(Moon et al., 2007). Sequences encoding antigenic peptides (shown in Table 1) EAE Induction and Clinical Evaluation
were fused to the N terminus of the I-Ab beta chain via a flexible polyglycine Mice were immunized subcutaneously with 100 mg of MOG peptide or 11
linker. Tetramers were produced in insect cells as previously described amino acid versions of homologous bacterial peptides emulsified in CFA con-
(Moon et al., 2007) with the exception that in some cases biotinylated p:I-Ab taining Mycobacterium tuberculosis. In addition, the mice received 200 ng of
monomers were purified on a Pierce Monomeric Avidin UltraLink Resin pertussis toxin (List Biological Laboratories) intravenously on the day of, and
(Thermo Scientific). Biotinylated p:I-Ab monomers were used to make tetra- 2 days after, peptide immunization. Individual animals were graded according
mers with streptavidin-phycoerythrin (PE) or streptavidin-allophycocyanin to clinical severity as follows: grade 0, no abnormality; grade 1, limp tail; grade
(APC) (Prozyme). 2, limp tail and hind limb weakness; grade 3, partial hind limb paralysis; grade
4, complete hind limb paralysis; as previously described (Fife et al., 2000).
Cell Enrichment and Flow Cytometry
Single cell suspensions were prepared from spleen and lymph nodes. Staining Statistical Analysis
with p:I-Ab-streptavidin-PE and p:I-Ab-streptavidin-APC tetramers was for 1 hr Two-tailed Student’s t tests, linear regressions, and Spearman’s Rho test were
at room temperature. Anti-PE and anti-APC magnetic beads were then added performed with Prism (Graphpad) software.
and bead-bound cells were enriched as previously described (Moon et al.,
2007; Tubo et al., 2013). Cells contained in the bound fraction were stained SUPPLEMENTAL INFORMATION
on ice with antibodies specific for cell surface molecules and analyzed on an
LSR II or Fortessa (Becton Dickinson) flow cytometer. Data were analyzed Supplemental Information includes one figure and one table and can be found
with FlowJo software. with this article online at http://dx.doi.org/10.1016/j.immuni.2014.12.022.
Peptides ACKNOWLEDGMENTS
Peptides used for immunization or ELISPOT were purchased from Genscript.
The peptides were 11 amino acids long with the putative nonamer core in the We thank J. Walter and A. Quade for technical assistance, S. McSorley for the
middle. The nonamer core sequences are shown Table 1 or the relevant fig- Aasf:I-Ab, RplF:I-Ab, and PmpG1:I-Ab tetramers, and all members of the Jen-
ures. Peptides were emulsified in CFA and 0.05 ml of emulsion containing kins Laboratory for helpful discussions. Grants from the NIH (T32 GM008244
10 mg of peptide was injected subcutaneously at the base of the tail. and F30 DK093242 to R.W.N., UL1 TR000114 to D.B., R01 AI107020 to
J.J.M., R01 AI080275 to K.N., R01 AI105816 and R01 AI040996 to B.S.K.,
ELISPOT R01 AI093553 to M.W., P01 AI035296 to B.T.F., and R37 AI027998, R01
Mice were immunized by injection of 10 mg of peptide or pools of peptides AI039614, P01 AI035296, and R01 AI103760 to M.K.J.) and the William F. Mil-
emulsified in CFA, as described above. Two weeks later, CD4+ T cells were ton Fund (to J.J.M.) supported this work.
isolated from the draining inguinal and para-aortic lymph nodes and purified
by positive selection with anti-CD4 magnetic beads (Miltenyi Biotec). The cells Received: July 19, 2014
were cultured for 24 hr with B6 splenocytes and candidate peptides at a final Accepted: December 22, 2014
concentration of 20 mM and analyzed for the presence of IFN-g-producing Published: December 25, 2014
cells by ELISPOT. The ELISPOT assay was adapted from a published protocol
(Streeck et al., 2009) and a commercially available kit (Merck Millipore). Individ- REFERENCES
ual peptides were assayed in triplicate.
Alanio, C., Lemaitre, F., Law, H.K., Hasan, M., and Albert, M.L. (2010).
Alanine Scanning Approach Enumeration of human antigen-specific naive CD8+ T cells reveals conserved
Single alanine substitutions were made at P-1 to P10 of test peptides. In cases precursor frequencies. Blood 115, 3718–3725.
where A was in the native sequence, V was substituted, with the exception of
Ben-Nun, A., Kerlero de Rosbo, N., Kaushansky, N., Eisenstein, M., Cohen, L.,
P4 or P6, where P was substituted. This was to avoid shifting the I-Ab-binding
Kaye, J.F., and Mendel, I. (2006). Anatomy of T cell autoimmunity to myelin
register because P is a preferred amino acid at P4 and P6 based on the I:Ab-
oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and
binding matrix (Zhu et al., 2003). The peptides were assayed by ELISPOT as
control of MOG-reactive T cells in H-2b mice. Eur. J. Immunol. 36, 478–493.
described above. The results were analyzed using the publicly available script
Birnbaum, M.E., Mendoza, J.L., Sethi, D.K., Dong, S., Glanville, J., Dobbins, J.,
‘‘heatmap.2’’ available for the statistical analysis program ‘‘R.’’
Ozkan, E., Davis, M.M., Wucherpfennig, K.W., and Garcia, K.C. (2014).
Deconstructing the peptide-MHC specificity of T cell recognition. Cell 157,
Identification of Bacterial Peptides with the Same TCR Contact
1073–1087.
Amino Acids as 2W, GP66, LLO, 3K, or MOG Peptides
The set of 1,632 complete bacterial proteomes was downloaded in fasta Campion, S.L., Brodie, T.M., Fischer, W., Korber, B.T., Rossetti, A.,
format from Uniprot (www.uniprot.org) using the publicly available batch Goonetilleke, N., McMichael, A.J., and Sallusto, F. (2014). Proteome-wide
retrieval perl script. Each of these proteomes was then parsed into all possible analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood
nine amino acid substrings (P1 to P9) and I-Ab-binding scores were generated donors. J. Exp. Med. 211, 1273–1280.
based on a published matrix (Zhu et al., 2003). The top 1% of predicted I-Ab- Chu, H.H., Moon, J.J., Kruse, A.C., Pepper, M., and Jenkins, M.K. (2010).
binding peptides from each bacterial proteome were then screened against Negative selection and peptide chemistry determine the size of naive foreign
2W, GP66, LLO, 3K, or MOG for overlap at amino acid positions 2, 5, 7, and peptide-MHC class II-specific CD4+ T cell populations. J. Immunol. 185,
8 using custom C++ scripts. 4705–4713.
Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc. 105
Cong, Y., Bowdon, H.R., and Elson, C.O. (1996). Identification of an immuno- Miller, S.D., Karpus, W.J., and Davidson, T.S. (2010). Experimental autoim-
dominant T cell epitope on cholera toxin. Eur. J. Immunol. 26, 2587–2594. mune encephalomyelitis in the mouse. Current protocols in immunology /
Fife, B.T., Huffnagle, G.B., Kuziel, W.A., and Karpus, W.J. (2000). CC chemo- edited by John E. Coligan ... [et al.] Chapter 15, Unit 15 11.
kine receptor 2 is critical for induction of experimental autoimmune encepha- Moon, J.J., Chu, H.H., Pepper, M., McSorley, S.J., Jameson, S.C., Kedl, R.M.,
lomyelitis. J. Exp. Med. 192, 899–905. and Jenkins, M.K. (2007). Naive CD4(+) T cell frequency varies for different epi-
Flesch, I.E., Woo, W.P., Wang, Y., Panchanathan, V., Wong, Y.C., La Gruta, topes and predicts repertoire diversity and response magnitude. Immunity 27,
N.L., Cukalac, T., and Tscharke, D.C. (2010). Altered CD8(+) T cell immunodo- 203–213.
minance after vaccinia virus infection and the naive repertoire in inbred and Moon, J.J., Chu, H.H., Hataye, J., Pagán, A.J., Pepper, M., McLachlan, J.B.,
F(1) mice. J. Immunol. 184, 45–55. Zell, T., and Jenkins, M.K. (2009). Tracking epitope-specific T cells. Nat.
Geginat, G., Schenk, S., Skoberne, M., Goebel, W., and Hof, H. (2001). A novel Protoc. 4, 565–581.
approach of direct ex vivo epitope mapping identifies dominant and subdom- Moon, J.J., Dash, P., Oguin, T.H., 3rd, McClaren, J.L., Chu, H.H., Thomas,
inant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J. Immunol. P.G., and Jenkins, M.K. (2011). Quantitative impact of thymic selection on
166, 1877–1884. Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+
Grover, H.S., Blanchard, N., Gonzalez, F., Chan, S., Robey, E.A., and Shastri, T cells. Proc. Natl. Acad. Sci. USA 108, 14602–14607.
N. (2012). The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can Murphy, D.B., Rath, S., Pizzo, E., Rudensky, A.Y., George, A., Larson, J.K.,
control parasite burden. Infect. Immun. 80, 3279–3288. and Janeway, C.A., Jr. (1992). Monoclonal antibody detection of a major self
Hoyne, G.F., Callow, M.G., Kuo, M.C., and Thomas, W.R. (1994). Inhibition of peptide. MHC class II complex. J. Immunol. 148, 3483–3491.
T-cell responses by feeding peptides containing major and cryptic epitopes: Obar, J.J., Khanna, K.M., and Lefrançois, L. (2008). Endogenous naive CD8+
studies with the Der p I allergen. Immunology 83, 190–195. T cell precursor frequency regulates primary and memory responses to infec-
Huseby, E.S., White, J., Crawford, F., Vass, T., Becker, D., Pinilla, C., Marrack, tion. Immunity 28, 859–869.
P., and Kappler, J.W. (2005). How the T cell repertoire becomes peptide and
Oxenius, A., Bachmann, M.F., Ashton-Rickardt, P.G., Tonegawa, S.,
MHC specific. Cell 122, 247–260.
Zinkernagel, R.M., and Hengartner, H. (1995). Presentation of endogenous
Jenkins, M.K., and Moon, J.J. (2012). The role of naive T cell precursor viral proteins in association with major histocompatibility complex class II:
frequency and recruitment in dictating immune response magnitude. on the role of intracellular compartmentalization, invariant chain and the TAP
J. Immunol. 188, 4135–4140. transporter system. Eur. J. Immunol. 25, 3402–3411.
Kersh, G.J., Miley, M.J., Nelson, C.A., Grakoui, A., Horvath, S., Donermeyer, Painter, C.A., and Stern, L.J. (2012). Conformational variation in structures of
D.L., Kappler, J., Allen, P.M., and Fremont, D.H. (2001). Structural and func- classical and non-classical MHCII proteins and functional implications.
tional consequences of altering a peptide MHC anchor residue. J. Immunol. Immunol. Rev. 250, 144–157.
166, 3345–3354.
Pepper, M., Pagán, A.J., Igyártó, B.Z., Taylor, J.J., and Jenkins, M.K. (2011).
Kotturi, M.F., Scott, I., Wolfe, T., Peters, B., Sidney, J., Cheroutre, H., von Opposing signals from the Bcl6 transcription factor and the interleukin-2 re-
Herrath, M.G., Buchmeier, M.J., Grey, H., and Sette, A. (2008). Naive precursor ceptor generate T helper 1 central and effector memory cells. Immunity 35,
frequencies and MHC binding rather than the degree of epitope diversity 583–595.
shape CD8+ T cell immunodominance. J. Immunol. 181, 2124–2133.
Rees, W., Bender, J., Teague, T.K., Kedl, R.M., Crawford, F., Marrack, P., and
Kwok, W.W., Tan, V., Gillette, L., Littell, C.T., Soltis, M.A., LaFond, R.B., Yang,
Kappler, J. (1999). An inverse relationship between T cell receptor affinity and
J., James, E.A., and DeLong, J.H. (2012). Frequency of epitope-specific naive
antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc. Natl.
CD4(+) T cells correlates with immunodominance in the human memory reper-
Acad. Sci. USA 96, 9781–9786.
toire. J. Immunol. 188, 2537–2544.
Reiley, W.W., Shafiani, S., Wittmer, S.T., Tucker-Heard, G., Moon, J.J.,
Legoux, F., Debeaupuis, E., Echasserieau, K., De La Salle, H., Saulquin, X.,
Jenkins, M.K., Urdahl, K.B., Winslow, G.M., and Woodland, D.L. (2010).
and Bonneville, M. (2010). Impact of TCR reactivity and HLA phenotype on
Distinct functions of antigen-specific CD4 T cells during murine
naive CD8 T cell frequency in humans. J. Immunol. 184, 6731–6738.
Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 107,
Li, L.X., and McSorley, S.J. (2013). B cells enhance antigen-specific CD4 T cell 19408–19413.
priming and prevent bacteria dissemination following Chlamydia muridarum
Robertson, J.M., Jensen, P.E., and Evavold, B.D. (2000). DO11.10 and OT-II
genital tract infection. PLoS Pathog. 9, e1003707.
T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 164,
Liu, X., Dai, S., Crawford, F., Fruge, R., Marrack, P., and Kappler, J. (2002). 4706–4712.
Alternate interactions define the binding of peptides to the MHC molecule
IA(b). Proc. Natl. Acad. Sci. USA 99, 8820–8825. Rudolph, M.G., Stanfield, R.L., and Wilson, I.A. (2006). How TCRs bind MHCs,
peptides, and coreceptors. Annu. Rev. Immunol. 24, 419–466.
Lucca, L.E., Desbois, S., Ramadan, A., Ben-Nun, A., Eisenstein, M., Carrié, N.,
Guéry, J.C., Sette, A., Nguyen, P., Geiger, T.L., et al. (2014). Bispecificity for Sabatino, J.J., Jr., Huang, J., Zhu, C., and Evavold, B.D. (2011). High preva-
myelin and neuronal self-antigens is a common feature of CD4 T cells in lence of low affinity peptide-MHC II tetramer-negative effectors during poly-
C57BL/6 mice. J. Immunol. 193, 3267–3277. clonal CD4+ T cell responses. J. Exp. Med. 208, 81–90.
Marrack, P., Scott-Browne, J.P., Dai, S., Gapin, L., and Kappler, J.W. (2008). Sant, A.J., Chaves, F.A., Leddon, S.A., and Tung, J. (2013). The control of the
Evolutionarily conserved amino acids that control TCR-MHC interaction. specificity of CD4 T cell responses: thresholds, breakpoints, and ceilings.
Annu. Rev. Immunol. 26, 171–203. Front. Immunol. 4, 340.
Maybeno, M., Redeker, A., Welten, S.P., Peters, B., Loughhead, S.M., Schmidt, J., Neumann-Haefelin, C., Altay, T., Gostick, E., Price, D.A.,
Schoenberger, S.P., Sette, A., and Arens, R. (2012). Polyfunctional CD4+ Lohmann, V., Blum, H.E., and Thimme, R. (2011). Immunodominance of
T cell responses to immunodominant epitopes correlate with disease activity HLA-A2-restricted hepatitis C virus-specific CD8+ T cell responses is linked
of virulent Salmonella. PLoS ONE 7, e43481. to naive-precursor frequency. J. Virol. 85, 5232–5236.
McSorley, S.J., Cookson, B.T., and Jenkins, M.K. (2000). Characterization of Stadinski, B.D., Zhang, L., Crawford, F., Marrack, P., Eisenbarth, G.S., and
CD4+ T cell responses during natural infection with Salmonella typhimurium. Kappler, J.W. (2010). Diabetogenic T cells recognize insulin bound to IAg7 in
J. Immunol. 164, 986–993. an unexpected, weakly binding register. Proc. Natl. Acad. Sci. USA 107,
Mendel, I., Kerlero de Rosbo, N., and Ben-Nun, A. (1995). A myelin oligoden- 10978–10983.
drocyte glycoprotein peptide induces typical chronic experimental autoim- Stetson, D.B., Mohrs, M., Mallet-Designe, V., Teyton, L., and Locksley, R.M.
mune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V (2002). Rapid expansion and IL-4 expression by Leishmania-specific naive
beta expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951–1959. helper T cells in vivo. Immunity 17, 191–200.
106 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.
Stewart-Jones, G.B., Simpson, P., van der Merwe, P.A., Easterbrook, P., T cells from a diverse repertoire produce different effector cell types during
McMichael, A.J., Rowland-Jones, S.L., Jones, E.Y., and Gillespie, G.M. infection. Cell 153, 785–796.
(2012). Structural features underlying T-cell receptor sensitivity to concealed Turner, S.J., Kedzierska, K., Komodromou, H., La Gruta, N.L., Dunstone, M.A.,
MHC class I micropolymorphisms. Proc. Natl. Acad. Sci. USA 109, E3483– Webb, A.I., Webby, R., Walden, H., Xie, W., McCluskey, J., et al. (2005). Lack
E3492. of prominent peptide-major histocompatibility complex features limits reper-
Streeck, H., Frahm, N., and Walker, B.D. (2009). The role of IFN-gamma Elispot toire diversity in virus-specific CD8+ T cell populations. Nat. Immunol. 6,
assay in HIV vaccine research. Nat. Protoc. 4, 461–469. 382–389.
Su, L.F., Kidd, B.A., Han, A., Kotzin, J.J., and Davis, M.M. (2013). Virus-specific Wucherpfennig, K.W., and Strominger, J.L. (1995). Molecular mimicry in T cell-
CD4(+) memory-phenotype T cells are abundant in unexposed adults. mediated autoimmunity: viral peptides activate human T cell clones specific
Immunity 38, 373–383. for myelin basic protein. Cell 80, 695–705.
Tan, A.C., La Gruta, N.L., Zeng, W., and Jackson, D.C. (2011). Precursor fre- Zehn, D., and Bevan, M.J. (2006). T cells with low avidity for a tissue-restricted
quency and competition dictate the HLA-A2-restricted CD8+ T cell responses antigen routinely evade central and peripheral tolerance and cause autoimmu-
to influenza A infection and vaccination in HLA-A2.1 transgenic mice. nity. Immunity 25, 261–270.
J. Immunol. 187, 1895–1902. Zhu, Y., Rudensky, A.Y., Corper, A.L., Teyton, L., and Wilson, I.A. (2003).
Tubo, N.J., Pagán, A.J., Taylor, J.J., Nelson, R.W., Linehan, J.L., Ertelt, J.M., Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide:
Huseby, E.S., Way, S.S., and Jenkins, M.K. (2013). Single naive CD4+ prediction of an I-Ab peptide-binding motif. J. Mol. Biol. 326, 1157–1174.
Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc. 107